Please login to the form below

Not currently logged in
Email:
Password:

ABPI's Stephen Whitehead steps down

Leaves the UK pharma trade body after four years as its CEO

Stephen WhiteheadThe Association of the British Pharmaceutical Industry's (ABPI) Stephen Whitehead has left the organisation after serving as CEO for four years.

Speaking on behalf of the board ABPI president John Kearney said: “We want to thank Stephen for the very significant contribution he has made to the transformation and success of the ABPI.

“We wish Stephen the best for the future.”

Whitehead joined the UK trade body in 2011, taking over from Richard Barker, and brought senior experience from Barclays and Allied Domecq.

Earlier in his career, Whitehead spent ten years at GlaxoSmithKline and Eli Lilly at UK, European and international levels.

Once he moved back to pharma he quickly made an impact at the ABPI and in 2012 picked up Healthcare Communiquétor of the Year at the Communiqué Awards in recognition of his positive impact at the Association.

The ABPI said it would now begin searching for a new CEO and in the meantime Alison Clough would continue as acting CEO.

2nd October 2015

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

Fearless Girl cover
25 Women Leaders in UK Healthcare
Women trailblazers helping to shape the future of healthcare (Part 1)...
Fearless Girl cover
25 women leaders in UK healthcare (part 2)
...
Curb your enthusiasm (if you want to impress)
How do you build trust in pharmaceutical marketing? Through what you say, not by how loud you shout....

Infographics